Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

DNA study sheds light on myxoma resistance
Australia released myxomatosis in 1950 to tackle the burgeoning rabbit population.
Modern rabbits compared with specimens from before 1950s outbreak

An unprecedented rabbit DNA study has shed light on how rabbits have acquired resistance to myxomatosis.

Research led by the University of Cambridge and the CIBIO Institute in Porto looked at DNA from nearly 200 rabbits spanning 150 years and thousands of miles.

The team sequenced nearly 20,000 genes to pinpoint mutations since the myxomatosis pandemic in the 1950s.

According to findings published in the journal Science, modern rabbits in the UK, France and Australia, have acquired resistance to the myxoma virus through the same genetic changes. They also discovered that this process relied on lots of small mutations in different genes, rather than big changes in single genes.

Findings also suggest the protein that helps rabbits fight myxoma, also has an antiviral effect on an unrelated virus, vesicular stomatitis.

Miguel Carneiro, from CIBIO said: “While battling myxoma, rabbits may have increased their resistance to other viruses including, perhaps, rabbit haemorrhagic disease which is killing so many animals right now.”

Australia released myxomatosis in 1950 to tackle the burgeoning rabbit population, which was impacting the country’s native plants and animals. It is thought that the European rabbit was introduced to the country in the 1850s and within a century the population grew to hundreds of millions.

Within three months of releasing myxomatosis, it had spread 2,000km and killed 99 per cent of infected animals. It was illegally introduced to France in 1952 and spread to the UK in 1953, with similarly devastating consequences in all three countries.

Myxoma continues to present a serious threat to rabbits. Lead author Dr Joel Alves said: “Viral evolution appears to be finding ways to counter the genetic adaptations which we’ve observed. Recent, more virulent recent strains of myxoma virus, have been found to be extremely immunosuppressive. So the arms race goes on.”

As rabbit populations collapse across the UK and mainland Europe, researchers said the findings could provide clues to the future of the species.

Become a member or log in to add this story to your CPD history

Applications open for MMI research grants

News Story 1
 RCVS' Mind Matters Initiative (MMI) has launched round two of its veterinary mental health research grants.

Researchers have until 11.59pm on Wednesday, 28 May 2025 to apply for a grant for research which reflects MMI's 2025 focus areas.

Only one Impact Grant was awarded last year, and so this year there are two Discovery Grants and one Impact Grants available. Each Discovery Grant is worth £5,000 and the Impact Grant is worth £15,000.

For more information or to apply, email researchgrants@rcvs.org.uk to contact the MMI team.

 

Click here for more...
News Shorts
BBC Radio 4 documentary addresses corporate fees

BBC Radio 4's File on 4 Investigates has released a documentary exploring how corporate-owned veterinary practices may be inflating bills to increase profit.

Released on 15 April, 'What's Happening To Your Vet Bills?' revealed the policies which many corporate groups have in place to increase their profits. This included targets and upgrades which veterinary teams are tasked with meeting on a regular basis.

It also features Anrich Vets, an independently-owned practice based in Wigan. Following the case of Staffordshire terrier Benjy, who is diagnosed with a tumour, the documentary shares how the team were able to offer contextualised care and advice to make the procedure as affordable as possible for his owners.

The documentary can be heard on demand on BBC iPlayer.